Beam stock forecast.

Complete Beam Global stock information by Barron's. View real-time BEEM stock price and news, along with industry-best analysis.

Beam stock forecast. Things To Know About Beam stock forecast.

Find the latest Beam Therapeutics Inc. BEAM analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.Their consensus HOOD stock forecast was that it could hit $13.36, which would represent a potential upside of 39.28% over the $9.59 closing price on 20 November, 2022. The highest Robinhood stock forecast 2023 prediction came in at $28 and the lowest warned it could slip to just $7. HOOD stock was also a ‘hold’, according to the …Beam has raised a $9.5 million Series A round. The company is working on a new web browser that completely rethinks the way you start a web session and browse the web. The startup is founded by Dom Leca and Sébastien Métrot. Dom Leca previo...Term Box: Best Beam forecast, Beam price prediction, Beam coin forecast, Beam finance tips, Beam cryptocurrency prediction, BEAM analyst report, Beam price predictions 2023, BEAM currency forecast, Beam forecast tomorrow, Beam technical analysis, Beam coin future price, BEAM projections, Beam market prognosis, Beam expected price. The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —. Analyst rating Based on 14 analysts giving stock ratings to BEAM in …

NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.Mar 21, 2023 · According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ... Nov 23, 2023 · Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.

Find real-time ROKU - Roku Inc stock quotes, company profile, news and forecasts from CNN Business.View the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ.

INFIBEAM INFIBEAM:- wait till breakout keep an eye on the stock Hello traders, As always, simple and neat charts so everyone can understand and not make it too complicated. rest details mentioned in the chart. will be posting more such ideas like this. Until that, like share and follow :) check my othe INFIBEAM:- wait till breakout keep an eye on the stock Hello …January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of...

Oct 28, 2023 · Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts.

Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ...

Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ...Find real-time BEEM - Beam Global stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.28: Annual revenue (last year) $22.0M: Annual profit (last ...Jul 15, 2023 · Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ... Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsA high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …

7 brokerages have issued 1 year target prices for Verve Therapeutics' stock. Their VERV share price targets range from $13.00 to $55.00. On average, they expect the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 147.5% from the stock's current price. View analysts price targets for VERV or view top ...Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years. Oct 15, 2020 · The Beam Therapeutics stock forecast is 57.069107374265 USD for 2024 November 25, Monday; and 177.367 USD for 2028 November 25, Saturday with technical analysis. Beam Therapeutics (BEAM) stock price prediction is 57.069107374265 USD. Perform stock investment research with our IBD research tools to help investment strategies. We provide the resources to help make informed decisions.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Beam Global share forecasts, stock quote and buy / sell signals below. According to present data Beam Global's BEEM shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global ( BEEM) Beam Global, the ...४ दिन पहिले ... What is Beam Global's stock price today? Beam Global is currently listed on NASDAQ under BEEM. One share of BEEM stock can currently be ...

The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)

Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.Term Box: Best Beam forecast, Beam price prediction, Beam coin forecast, Beam finance tips, Beam cryptocurrency prediction, BEAM analyst report, Beam price predictions 2023, BEAM currency forecast, Beam forecast tomorrow, Beam technical analysis, Beam coin future price, BEAM projections, Beam market prognosis, Beam expected price. Ring beams are a type of support used in construction to connect walls together and increase the load capacity for the walls. Ring beams surround the foundation, and walls are built upon the ring. In some projects, an additional ring beam i...Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60. GLBE Stock 12 Months Forecast. $46.11. (31.33% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Global-e Online in the last 3 months. The average price target is $46.11 with a high forecast of $50.00 and a low forecast of $41.00. The average price target represents a 31.33% change from the last price of $35.11.(See Tritium stock forecast on TipRanks) Beam Global . Beam Global, the second EV charging stock we’re looking at, provides a range of power products for use in a variety of charging and battery ...Feb 1, 2023 · (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...

Find real-time ADPT - Adaptive Biotechnologies Corp stock quotes, company profile, news and forecasts from CNN Business.

Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.

The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46.Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46.Apr 18, 2023 · Also, the market prices MUSA at a forward multiple of 11.67, below the sector median value of 15.34 times. Thus, MUSA at least ranks as one of the stocks to watch. Finally, Wall Street analysts ... The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago.See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Mar 21, 2023 · According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ... Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global ( BEEM) Beam Global, the ...Find real-time AVGO - Broadcom Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $10.95: Annual revenue (last year) $33.2B: Annual profit ...

... price action for Beam Therapeutics (BEAM) ... In the historical earnings table above, you can find BEAM historical earnings dates and the historical stock price ...Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... Beam has raised a $9.5 million Series A round. The company is working on a new web browser that completely rethinks the way you start a web session and browse the web. The startup is founded by Dom Leca and Sébastien Métrot. Dom Leca previo...Stock Splits: Mergers & Acquisitions: Business Services/Equipment M&A Construction M&A General Contractors & Builders M&A Consumer Goods M&A Sporting Goods & Activities M&A Office Supplies M&A Food & Beverage M&A Beverages & Wineries M&A Cigarettes & Tobacco M&A Marijuana Stocks M&A Apparel Stores M&A Department Stores M&A …Instagram:https://instagram. bancos en eeuuouter furnituredia pricetexas oil stocks The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ...About the Beam Global stock forecast. As of 2023 November 26, Sunday current price of BEEM stock is 5.850$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Beam Global stock price has been showing a declining tendency so we believe that similar market segments were not very popular in … heating oil futures pricesgenie energy ltd BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …This morning Beam, an insurtech startup that provides dental coverage to corporate employees, announced that it has closed an $80 million Series E. Mercato-affiliated Traverse led the investment, with Nationwide insurance joining the deal. ... upcoming dividend Stock Price Forecast The 3 analysts offering 12-month price forecasts for Velo3D Inc have a median target of 2.00, with a high estimate of 2.10 and a low estimate of 1.48.Nov 17, 2023 · The mean of analysts' price targets for Beam Therapeutics Inc. (BEAM) points to an 81.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...